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Abstract 
 
Changes to the redox status of biological systems have been implicated in the 
pathogenesis of a wide variety of disorders. Sensitive quantification of these changes 
has been developed using a novel fluorescent probe containing a redox-sensitive 
nitroxide moiety. As well as being able to selectively detect superoxide radical in 
vitro, overall changes to the cellular redox environment can be measured using flow 
cytometry on the basis of nitroxide reduction. The reversible nature of the probe’s 
detection mechanism offers the unique advantage of being able to monitor redox 
changes in both oxidising and reducing directions in real time. 
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An excess of pro-oxidants in a biological system can lead to the damage of vital 
cellular components such as proteins, lipids and DNA. Such an imbalance in the 
redox environment [1] of a cell is described as oxidative stress, and has been 
implicated in a variety of disorders including cancer, ischemia-reperfusion injury and 
neurodegeneration [2-4]. Therefore, techniques which are able to quantify and 
visualise the redox environment of biological systems are crucial tools for 
investigating links between oxidative stress and disease, and for determining the 
efficacy of potential antioxidant therapies. 
 
Compounds that have potential in this regard are the stable nitroxide radicals. 
Nitroxides have been applied as biophysical probes in conjunction with electron 
paramagnetic resonance (EPR) spectroscopy to monitor properties such as membrane 
structure [5] and oxygen concentration [6]. They have also found application in 
monitoring changes in the cellular redox environment on the basis of their metabolism 
to the reduced hydroxylamines, which are EPR silent. This one electron reduction is 
the primary metabolic fate of nitroxides, and is dependent on the redox status of the 
biological system under study [7-12]. 
 
R2NO R2NOH
1e-
Nitroxide Hydroxylamine  
 
Nitroxide reduction is an intracellular process [9] and is mediated by various 
reductants such as ascorbate, ubiquinol, tocopherol, and, indirectly, glutathione [9, 
11]. In the absence of these reducing equivalents, and in the presence of oxygen, the 
equilibrium between the oxidised nitroxide molecule and the reduced hydroxylamine 
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will be shifted towards the more oxidised of the species. Consequently, nitroxide 
radicals are more persistent in systems under oxidative stress. Since various cellular 
redox processes are able to mediate conversion between the hydroxylamine and 
nitroxide species, the ratio of these two states is indicative of the overall ‘reducing 
capacity’, or redox environment, of the cell. The reversible nature of hydroxylamine 
formation adds the important advantage of being able to follow variations in the redox 
environment of biological systems over time. 
 
Nitroxides have been applied extensively in the field of EPR imaging as in vivo 
probes of redox status, especially in the context of hypoxic tumour environments [11-
15]. The characteristic 3-line EPR spectrum of paramagnetic nitroxides can be 
monitored with time in biological samples. A loss in EPR signal intensity is indicative 
of hydroxylamine formation, and thus provides a measure of the reducing capacity in 
these samples. A drawback of this approach is that EPR signal loss may not always 
arise from hydroxylamine formation. Decreases in nitroxide concentration from the 
region of interest by some other means, such as excretion, also produces a loss of EPR 
signal intensity. Furthermore, EPR imaging techniques suffer from limited spatial 
resolution and are therefore unsuitable to monitor processes occurring at the 
subcellular level. 
 
An alternative and complementary approach is to use nitroxide probes covalently 
linked with fluorescent structures possessing excitation and emission profiles of 
biological relevance. As shown by Blough [16, 17], the covalent linkage of a 
nitroxide moiety to a fluorophore efficiently quenches the excited states which lead to 
fluorescence. Reaction of the nitroxide free radical to form a diamagnetic species 
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removes this quenching effect and thereby leads to a significant increase in the 
fluorescence yield of the compound. The presence of the nitroxide in these 
“profluorescent” species thus acts as a redox sensitive on-off switch for the 
fluorescence of the molecule. In a biological context, this provides a convenient 
method for distinguishing between relative levels of the diamagnetic hydroxylamine 
(high fluorescence, reducing conditions) and paramagnetic nitroxide (low 
fluorescence, oxidising conditions) as a reflection of the redox status of the cell.  
 
Herein, we describe a unique example of a biologically relevant profluorescent 
nitroxide probe based on the fluorescein class of fluorescent dyes. Fluoresceins 
possess excellent fluorescence quantum yields, have high water solubility, and have 
excitation and emission profiles largely free of interference from biological molecules 
[18]. Incorporating a redox sensitive nitroxide into the fluorescein dye combines these 
advantages with the potential to probe the cellular redox environment using 
fluorescence microscopy and flow cytometry. The new nitroxide probe has the 
significant advantage that the spin is very proximate to the aromatic fluorophore to 
maximise quenching. By constructing a molecule with the nitroxide built into the 
fluorescein carbon skeleton, fluorescence arising from fluorophore/spin cleavage is 
prevented. This novel probe has the potential to provide real-time and reversible 
responses relating to cellular oxidative stress and the impacts of pro- and anti-
oxidants.  
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Experimental Procedures 
Synthesis of 5,6-dibromo-1,1,3,3-tetramethylisoindolin-2-yloxyl (1). To a stirred 
solution of 5,6-dibromo-1,1,3,3-tetramethylisoindoline 36 (1.3 g, 3.9 mmol) in MeOH 
(9 mL) and MeCN (370 µL) at room temperature, NaHCO3 (370 mg, 4.4 mmol, 1.1 
equiv) and Na2WO4·2H2O (150 mg, 0.45 mmol, 0.12 equiv) were added, followed by 
H2O2 (30 %, 3.2 mL, 28.3 mmol, 7.3 equiv). After 120 hours, water (~60 mL) was 
added to the reaction mixture, which was then extracted with DCM (3 × 60 mL). The 
combined organics were washed with H2SO4 (2M, 2 × 50 mL) and brine (2 × 50 mL), 
dried (Na2SO4) and the solvent was removed under reduced pressure to give a yellow 
crystalline solid, 5,6-dibromo-1,1,3,3-tetramethylisoindolin-2-yloxyl 21, (1.19 g, 88 
%), which recrystallised from MeCN to give yellow needles (0.93 g, 68 %) mp 
254−256 °C (decomp.) (lit. [19] 258 °C); νmax (ATR-FTIR): 3018 (aryl CH), 2976 
(alkyl CH), 1468 and 1444 (aryl C-C), 1429 (NO), 638 (aryl C-Br) cm
-1
. These data 
agree with those reported previously by Micallef et al.[19]. 
 
Synthesis of 5,6-dicyano-1,1,3,3-tetramethylisoindolin-2-yloxyl (2). A mixture of 
5,6-dibromo-1,1,3,3-tetramethylisoindolin-2-yloxyl 21 (1.75 g, 5.03 mmol), 
K4[Fe(CN)6]·3H2O (868 mg, 2.05 mol, 0.4 equiv, pre-ground), Na2CO3 (1.07 g, 10.16 
mmol, 2.0 equiv) and Pd(OAc)2 (60 mg, 0.26 mmol, 5 mol%) was heated in DMAC 
(11 mL) at 130 °C for 3 days. The solution was subsequently poured onto water and 
extracted with CHCl3. The organic phase was washed with saturated NaCl solution, 
dried (Na2SO4) and the solvent removed under reduced pressure to give crude dinitrile 
2 and remaining starting material. Purification by column chromatography (CHCl3) 
gave 5,6-dicyano-1,1,3,3-tetramethylisoindolin-2-yloxyl 2 (869 mg, 3.62 mmol, 72 
%) mp 243-247 °C (lit. [20] 243-248 °C); IR (ATR) νmax: 3039 (alkyl CH), 2979 (aryl 
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CH), 2231 (CN), 1465(aryl C-C), 1432 (NO) cm
-1
. These data agree with those 
reported previously by Barrett et al.[20]. 
 
Synthesis of 5,6-dicarboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (3). A 
suspension of 5,6-dicyano-1,1,3,3-tetramethylisoindolin-2-yloxyl 2 (453 mg, 1.89 
mmol) in KOH (2.5 M, 7.5 mL) and absolute ethanol (1.6 mL) was heated at reflux 
for 16 h. The resultant pale yellow solution was washed with Et2O (2 × 50 mL), 
acidified with H2SO4 (2M) and extracted with Et2O (3 × 50 mL). The organic phase 
was dried (Na2SO4) and the solvent removed under reduced pressure to give 5,6-
dicarboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl 3 (521 mg, 1.87 mmol, 99 %) mp 
246-250 °C (decomp.); νmax (ATR-FTIR): 3545 and 3469 (OH), 2975 (alkyl CH), 
2906 (aryl CH), 1705 (C=O), 1432 (NO) cm
−1
; +EI MS found M
+ 
278.10288
 
(0.11 
ppm from calc. mass of C14H16NO5
•
): m/z 278 (M
+
, 5 %), 260 (65), 245 (38), 230 
(100), 215 (82), 171 (50). Recrystallisation from water produced crystals that were of 
sufficient quality to obtain an x-ray crystal structure (data not shown). 
 
Synthesis of 1,1,3,3-tetramethyl-5,7-dioxo-3,5,6,7-tetrahydro-1H-furano[3,4-
f]isoindol-2-yloxyl (4). 5,6-Dicarboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl 3 (610 
mg, 2.19 mmol) was refluxed in Ac2O (10 mL) for 4 h after which a clear orange 
solution was obtained. Removal of the solvent under reduced pressure gave 1,1,3,3-
tetramethyl-5,7-dioxo-3,5,6,7-tetrahydro-1H-furano[3,4-f]isoindol-2-yloxyl 4 (570 
mg, 2.19 mmol, 100 %) mp 246-250 °C (decomp.); νmax (ATR-FTIR): 2983 (alkyl 
CH), 2937 (aryl CH), 1845 and 1776 (C=O), 1621 (aryl C-C), 1442 (NO) cm-1; +EI 
MS found M+ 260.09340 (4.30 ppm from calc. mass of C14H14NO4•): m/z 260 (M+, 
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95 %), 245 (50), 230 (97) 215 (100), 171 (80). X-ray quality crystals could be attained 
by slow crystallisation from Ac2O (data not shown). 
 
Synthesis of 5-carboxy-6-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-1,1,3,3-
tetramethylisoindolin-2-yloxyl (7). Nitroxide anhydride 4 (100 mg, 0.384 mmol) 
was added to a solution of resorcinol (85 mg, 0.772 mmol, 2 equiv) in MeSO3H (0.78 
mL). The mixture was heated at 85 °C for 24 h and subsequently poured onto 
ice/water. The solution was treated with NaOH (5 M), to ensure total dissolution of 
the crude product. The solution was acidified with dropwise addition of conc. HCl 
and the product was partitioned into Et2O (3 × 30 mL) and dissolved by addition of 
MeOH (~20 mL). The solution was filtered to remove insoluble material, dried 
(Na2SO4) and the solvent was removed under reduced pressure, to give the crude 
product 7. Purification by column chromatography (20 % EtOH/80 % EtOAc with 0.1 
% v/v AcOH), gave 7 as a dark orange crystalline solid (158 mg, 92 %) mp > 300 °C 
(decomp.); νmax (ATR-FTIR): 3342 (OH), 2977 and 2927 (alkyl CH), 2856 (aryl CH), 
1733 (C=O), 1442 (NO) cm
-1
;
 
+EI MS found M
+ 
444.1445
 
(0.5 ppm from calc. mass 
of C26H22NO6
•
): m/z 444 (M
+
, 100 %), 430 (43), 414 (37), 369 (48) 329 (55). See 
HPLC trace in supporting information. 
 
Synthesis of 5-carboxy-6-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-2-methoxy-1,1,3,3-
tetramethylisoindoline (8). A solution of fluorescein nitroxide 7 (20 mg, 0.045 
mmol) in DMSO (1.4 cm
3
) had FeSO4·7H2O (25 mg, 0.090 mmol, 2 equiv) and H2O2 
(30 % aqueous solution, 9 µL) added. The reaction mixture was stirred under argon 
for 30 min at room temperature after which it was poured onto NaOH (2M, 10 cm
3
) 
and washed with Et2O (2 × 10 cm
3
) and CHCl3 (2 × 10 cm
3
) to remove DMSO 
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present. The aqueous phase was acidified with dropwise addition of conc. HCl and 
partitioned into Et2O (30 cm
3
) to remove aqueous salts. MeOH (~5 mL) was added to 
dissolve the product and the mixed solvent removed under reduced pressure to give 
the crude product. Purification by column chromatography (20 % EtOH/80 % EtOAc 
with 0.1 % v/v AcOH), gave the fluorescein methyl trap 8 as a dark orange solid (14 
mg, 0.030 mmol, 67 %) mp > 300 °C (decomp.); δH: (MeOD-d4); 1.38 (6H, br s, 
CH3), 1.54 (6H, br s, CH3), 3.78 (3H, s, OCH3), 6.56 (2H, dd, J 2.4 and 8.8 Hz, 2’-H 
and 7’-H), 6.67 (2H, d, J 2.4 Hz, 4’-H and 5’-H), 6.72 (2H, d, J 8.8 Hz, 1’-H and 8’-
H), 7.00 (1H, s, 7-H), 7.78 (1H, s, 4-H); δC: (MeOH-d4); 30.7 (CH3), 30.8 (CH3), 66.0 
(OCH3), 68.2 (alkyl C*), 68.6 (alkyl C*), 103.7 (C4’ and C5’), 112.6 (C1’a and 
C8’a), 115.8 (C2’ and C7’), 120.1 (C7), 120.5 (C4), 130.9 (C3), 131.1 (C1’ and C8’), 
131.2 (C8),  149.1 (C4’a and C5’a), 153.8 (C5 and C6), 155.4 (C1), 165.4 (C3’ and 
C6’), 172.2 (C=O); νmax (ATR-FTIR): 3305 (OH), 2962 and 2925 (alkyl CH), 2852 
(aryl CH), 1729 (C=O) cm
-1
; +ESI MS found (M+H)
+ 
460.174976
 
(2.3 ppm from 
calc. mass of C27H26NO6
+
): +EI MS m/z 459 (M
+
, 10 %), 444 (100), 369 (30). 
 
 
Fluorescence Spectroscopy 
Xanthine oxidase from bovine milk (Grade III, ammonium sulphate suspension, 1-2 
units/mg protein), hypoxanthine (≥99 %) and diethylenetriamine/nitric oxide adduct 
(≥97 %) were purchased from Sigma-Aldrich.  
 
Fluorescence measurements were conducted on a Varian Cary Eclipse fluorescence 
spectrophotometer fitted with a microplate reader accessory. Fluorescein-nitroxide 7 
was excited at 492 nm, and the emission detected in the range 492 nm – 600 nm. 
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Reactions with ascorbate, superoxide and nitric oxide were conducted in 0.01 M 
phosphate buffered saline, pH 7.4 (PBS). Nitroxide probe 7, or the alkylated 
derivative 8, was added to samples at a final concentration of 1 µM from a 10 mM 
stock solution prepared in DMSO. Stock solutions of the probes were stored in a -23 
°C freezer. 
 
For superoxide assays, 1.4 mg of hypoxanthine was dissolved in 1 mL of 30 mM 
NaOH solution to make a 10 mM stock solution, which was made fresh prior to each 
assay.  Xanthine oxidase was diluted in PBS just prior to measurement and then added 
to the reaction solution at a final concentration of 0.03 units/mL.  
 
Nitric oxide assays were conducted using diethylenetriamine/nitric oxide adduct 
(DETA/NO), which spontaneously releases nitric oxide in aqueous solution [21]. 
DETA/NO (1.6 mg) was dissolved in 1 mL of 10 mM NaOH solution to give a 10 
mM stock solution, which was made fresh prior to each assay. For the oxygen-free 
experiment, PBS solution containing 1 µM fluorescein-nitroxide 7 was bubbled with 
N2 gas for 30 mins and sealed, prior to the addition of DETA/NO solution. 
 
For the reduction of fluorescein-nitroxide 7 with ascorbate, a fresh 0.5 M stock 
solution of ascorbate was prepared by dissolving ascorbic acid (1.7612 g) and NaOH 
(0.4000 g) in 20 mL H2O (pH ≈ 6). Appropriate dilutions were made to achieve a 
final ascorbate concentration of 100 µM. 
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Flow Cytometry 
Cells (h TERT immortalised fibroblasts) were seeded into a number of separate flasks 
corresponding to the number of separate treatments (each treatment conducted in 
triplicate on separate samples) to be performed. They were then cultured in RPMI 
1640 growth medium, containing 10 % fetal calf serum and incubated at 37 °C in a 5 
% CO2/air atmosphere. Cells were grown to the required density and then treated 
accordingly. Nitroxide probe 7, or the alkylated derivative 8, was added to all cell 
samples at a final concentration of 1 µM from a 10 mM stock solution prepared in 
DMSO. Stock solutions of the probes were stored in a -23 °C freezer.  
 
For 2DG treated cells, a fresh 2 M stock solution was prepared in 0.1 M phosphate 
buffered saline, pH 7.4. Addition of 2DG to cells were made to give final 
concentrations of 1 mM, 10 mM and 20 mM. These cells were incubated in the 
presence of 2DG for 4 hours.  
 
For ROT treated cells, a fresh 100 mM stock solution was prepared in DMSO, which 
was further serial diluted in DMSO to ensure the final concentration of DMSO in 
treated cells did not exceed 0.1 %. ROT was added to cells and incubated for a period 
of 30 minutes.  
 
Following the relevant treatment periods, the medium was removed from the cells and 
washed with PBS (5 mL). Cells were subsequently washed with EDTA (~2 mL) and 
then incubated in RPMI 1640 growth medium, containing 10 % fetal calf serum and 
trypsin for 5 minutes to detach cells from the flask. Cells were then collected and 
centrifuged (1200 g, 5 minutes). After discarding the supernatant, the cell pellet was 
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resuspended in PBS before being centrifuged once more (1200 g, 5 minutes). 
Supernatant was discarded, and the cells were resuspended in PBS and analysed on a 
Becton Dickinson FACScan flow cytometer. The nitroxide probe 7 was excited using 
an air-cooled argon laser at 488 nm, and emission was detected at 530 nm. Statistical 
analysis was conducted on a count of at least 20,000 cells. 
 
Fluorescence Imaging 
Cells (h TERT immortalised fibroblasts) were cultured in RPMI 1640 growth 
medium, containing 10 % fetal calf serum and incubated at 37 °C in a 5 % CO2/air 
atmosphere. Stock solutions of the fluorescein-nitroxide probe 7 were made fresh in 
DMSO at a concentration of 10 mM, which was added to the cells to give a final 
concentration of 1 µM. After incubation of the cells for 15 minutes, 45 minutes, or 2 
hours in the presence of the nitroxide probe 7, cells were washed three times and then 
incubated with L-15 media in an incubator stage attached to an Applied Precision 
Deltavision Deconvolution Microscope. 
 
Results 
Synthesis 
Synthesis of fluorescein is commonly achieved via the condensation of a substituted 
phthalic anhydride with two equivalents of resorcinol. In order to incorporate the 
nitroxide functionality within the fluorescein structure, a novel nitroxide-based 
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phthalic anhydride was synthesised and used as a direct precursor to the final probe 
molecule (Scheme 1). 
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Scheme 1. (a) K4[Fe(CN)6].3H2O, Pd(OAc)2, Na2CO3, DMAC, 130°C, 72 hrs; (b) 
KOH, EtOH/H2O, reflux, 16 hrs; (c) Ac2O, reflux, 4 hrs; (d) Resorcinol, MeSO3H, 
85°C, 24 hrs; (e) NaOH; (f) HCl; (g) FeSO4.7H2O, H2O2, DMSO, RT, 1 hr 
 
The nitroxide anhydride was obtained by cyanation of the previously reported [19] 
dibromo species 1, followed by hydrolysis to give the di-carboxy derivative 3. 
Subsequent cyclisation in acetic anhydride afforded the nitroxide-substituted phthalic 
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anhydride 4. Two equivalents of resorcinol were then combined with 4 in 
methanesulfonic acid at 85 °C for 24 hours to give the sulfonate ester intermediate 5 
[22] which was subsequently treated with NaOH to produce the fluorescein dianion 6. 
In aqueous solutions, fluorescein derivatives are known to exist in cationic, neutral, 
anionic and dianionic forms, each possessing its own absorption and fluorescence 
characteristics (Scheme 2) [18, 23]. Conversion between these species is a facile 
process dependent on the pH of the aqueous environment. 
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Scheme 2. Protolytic equilibria of fluorescein in aqueous solutions 
 
Although the dianion is the desired fluorescent species, fluoresceins are typically 
isolated from acidic solution for ease of purification and handling. Thus isolation of 
the final product was achieved by acidification to precipitate the fluorescein-nitroxide 
7, which, after purification by chromatography, was obtained in 92 % yield. High-
resolution mass spectrometry and HPLC facilitated characterisation of the nitroxide 
probe, however NMR identification was not possible due to the paramagnetic 
broadening effect of the free radical. 
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Nitroxide 7 was further derivatised to give the, non-radical, methoxyamine 8 in 67 % 
yield. As well as being useful for NMR characterisation, this methoxyamine 
derivative provided a suitable positive control for fluorescence experiments with 7, 
due to its structural similarity, but without the nitroxide functionality and fluorescence 
quenching effect of the free radical. The 
13
C spectrum confirmed the cationic 
conformation of the derivative. 
 
In Vitro Spectroscopic Properties and Response to 
Oxidising/Reducing Species 
Due to the pH dependence of the fluorescence of fluorescein-based compounds, the 
spectra of 7 and 8 (shown in Figure 1) were recorded in 0.1 M NaOH solution, where 
fluoresceins are highly fluorescent and the quantum yield of the parent compound 
fluorescein is known [24]. A 1 µM solution of the nitroxide probe 7 in 0.1 M NaOH 
exhibited relatively weak fluorescence with an excitation wavelength at 492 nm, and 
an emission maximum at 514 nm. The alkylated, non-radical methoxyamine 
derivative 8 produced an identical fluorescence profile, but with a significantly higher 
intensity than that of the nitroxide precursor (Figure 1). 
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Figure 1. Fluorescence spectra of fluorescein-nitroxide 7 (---) and methoxyamine 
derivative 8 (―) excited at 492 nm in 0.1M NaOH normalised to 1 µM 
 
Fluorescein (ФF = 0.93) [24] in 0.1 M NaOH was used as a standard for the 
calculation of quantum yields of both nitroxide 7 and methoxyamine 8. 
Understandably, the quantum yield of the fluorescein-methoxyamine 8 (ФF = 0.93) 
mirrored that of the unsubstituted fluorescein, while the fluorescein-nitroxide 7 (ФF = 
0.15) had a considerably lower quantum yield than either of the non-radical 
derivatives. 
 
Removal of the nitroxide free radical in the novel probe 7 by one-electron reduction 
to the hydroxylamine resulted in a corresponding increase in fluorescence intensity at 
514 nm. This reduction was facilitated by a large excess of hydrazine hydrate (175 
mM) in a 1 µM solution of 7 in 0.1 M NaOH. The reversibility of hydroxylamine 
formation was subsequently demonstrated by vigorous stirring with O2 present in the 
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atmosphere, resulting in a concomitant decrease in fluorescence consistent with 
reformation of the nitroxide radical. This reduction and re-oxidation cycle was 
repeated twice and demonstrates the ability of the fluorescein-nitroxide probe to 
dynamically respond to various reductants and oxidants. 
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Figure 2. Fluorescence intensity at 514 nm of fluorescein-nitroxide probe 7 in 0.1 M 
NaOH taken every 1 minute. Dark squares () indicate measurements taken without 
agitation in the presence of a large excess of hydrazine hydrate (175 mM). Data 
indicated by the light squares () were recorded with vigorous mixing in atmospheric 
oxygen between each measurement. 
 
As previously mentioned, there are a number of pH-dependent protolytic 
conformations available to fluorescein derivatives, each possessing their own 
absorption and fluorescence characteristics. As such, the fluorescence properties of 
the novel probes 7 and 8 are also pH-dependent (see Supporting Information). At 
biological pH, there is a smaller change in fluorescence between the nitroxide radical 
derivative and its diamagnetic analogue as compared to the same measurements 
conducted in a highly basic environment. Thus reduction of nitroxide probe 7 with a 
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biologically relevant reductant such as ascorbate produced a 2.2-fold increase in 
fluorescence at neutral pH. This process of hydroxylamine formation is the primary 
metabolic fate of nitroxides in vivo, with a fluorescence increase reflecting a primarily 
reducing environment. (Figure 3).  
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Figure 3. Fluorescence response of the fluorescein-nitroxide 7 (1 µM) following 
reaction with ascorbate (100 µM) after 13 mins in 0.01 M phosphate buffered saline, 
pH 7.4. Error bars represent the standard deviation of 3 separate samples. 
 
The in vitro responses of the fluorescein-nitroxide (7) and those of its non-radical, 
alkylated derivative (8) towards biologically relevant pro-oxidants were also 
evaluated at biological pH (0.01 M phosphate buffered saline, pH 7.4). The pro-
oxidants tested included O2
•-
, H2O2, 
•
OH and NO
•
. Notably, superoxide (O2
•-
) 
generated by the action of xanthine oxidase on hypoxanthine [25], gave a 2.2 fold 
increase in fluorescence (Figure 4, Panel A). Similarly, generation of NO
•
 by the 
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decomposition of diethylenetriamine/nitric oxide adduct (DETA/NO) [21] led to a 
2.7-fold fluorescence increase (Figure 4, Panel B).  
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Figure 4. Fluorescence response of the fluorescein-nitroxide 7 to superoxide and 
nitric oxide. (A) Fluorescein nitroxide 7 blank (); fluorescein-nitroxide 7 exposed 
to superoxide generated by the action of 0.03 units/mL of xanthine oxidase on 100 
µM hypoxanthine (). (B) Fluorescein nitroxide 7 blank (); fluorescein-nitroxide 7 
exposed to nitric oxide released by 500 µM DETA/NO (). Measurements taken at a 
concentration of 1 µM of 7 in 0.01 M phosphate buffered saline, pH 7.4. Each point is 
the mean of three independent samples (±SD) 
 
However, incubation of the fluorescein-nitroxide 7 with NO
•
 generated by DETA/NO 
in de-oxygenated buffer produced only a negligible increase in fluorescence output 
(data not shown). This suggests that the increase seen in air equilibrated buffer 
(Figure 4, Panel B) probably arises from reaction with higher oxides of nitrogen such 
as NO2
•
 and N2O3 [26]. 
 
The other pro-oxidants tested, H2O2 and 
•
OH, did not lead to any significant 
fluorescence response (data not shown). Consequently under these conditions, the 
probe displays in vitro selectivity for superoxide and only responds to NO
• 
via 
interaction with higher oxide by-products. 
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To confirm the role of the radical in the fluorescence response for the nitroxide probe, 
the same assays were conducted using the non-radical alkylated analogue 8. Exposure 
of 8 to the redox active species O2
•-
, H2O2, 
•
OH and NO
•
 resulted in no change in the 
fluorescence detected at 514nm (results not shown). This demonstrates the chemical 
stability of the fluorophore with respect to these species, and confirms that loss of the 
nitroxide spin is responsible for the fluorescence increases observed for 7 in response 
to superoxide and nitric oxide. 
 
Flow Cytometry 
The in vitro results demonstrate the responsiveness of the fluorescein nitroxide probe 
7 towards important redox-active species under relevant biological conditions. In a 
cellular context however, the nitroxide probe is less likely to have direct interaction 
with these species due to their low steady state concentrations compared to the 
intracellular reducing agents which facilitate bioreduction to the hydroxylamine. 
Thus, while there is an increase in the fluorescence of the nitroxide 7 in response to 
superoxide itself, it is the overall redox environment, or reducing capacity, of a cell – 
to which levels of radicals such as superoxide will contribute – which is the most 
important variable contributing to the fluorescence of 7 in biological samples. 
 
Fibroblasts exhibiting a normal phenotype were immortalised with h TERT and used 
as a convenient vehicle for studying the cellular redox status under normal 
physiological conditions. In proliferating h TERT immortalised fibroblasts, 
incubation with the nitroxide probe 7 for 45 minutes produces a single population at 
high fluorescence - reflecting complete reduction of the nitroxide to the more 
fluorescent hydroxylamine (Figure 5, Panel A). Conversely, a confluent sample of h 
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TERT immortalised fibroblasts incubated with 7 produces a fluorescence histogram 
indicating the presence of two cellular populations. The population of cells with high 
fluorescence represents those cells that are able to reduce the nitroxide probe to the 
highly fluorescent hydroxylamine. The second population possesses much lower 
levels of fluorescence and represents those cells that retain the probe in its non-
reduced nitroxide oxidation state (Figure 5, Panel B).  
 
To confirm that these differences in fluorescence arise from changes in redox state 
rather than variability in the uptake, retention, excretion or localisation of the 
fluorophore, analogous samples of h-TERT immortalised fibroblasts were incubated 
with the alkyl derivative 8 for 45 mins. This compound provides a convenient positive 
control as it contains the same fluorophore, but without the fluorescence quenching 
effect and redox sensitivity of the nitroxide species. As expected, these measurements 
produce a single population at high fluorescence (Figure 5, Panel C). This confirms 
that the split population measured with 7 in confluent h TERT immortalised 
fibroblasts arises from differential redox status reflected by different levels of 
R2NO
•
/R2NOH.  
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Figure 5. Each panel contains a log density plot of side scatter vs. fluorescence 
intensity (FL-1, 530 nm), and a histogram of fluorescence intensity (FL-1, 530 nm). 
A) Proliferating h TERT immortalised fibroblasts incubated with 7 (1 µM, 45 mins); 
B) Confluent h TERT immortalised fibroblasts incubated with 7 (1 µM, 45 mins); C) 
confluent h TERT immortalised fibroblasts incubated with 8 (1 µM, 45 mins); D) 
same as in ‘B)’ plus treatment with 2DG (20 mM, 4 hours) and ROT (100 nM, 30 
mins) 
 
Thus for confluent fibroblasts, the nitroxide probe 7 showcases the different redox 
environments of the cycling and non-cycling fractions of a cell population. In the 
cycling population of fibroblasts the primary means of energy production is anaerobic 
glycolysis, which results in an overall reducing cellular environment [27]. As the 
fibroblasts become more confluent, a non-cycling population of cells emerges which 
primarily relies on aerobic respiration as an energy source due to a lack of glucose 
availability [27]. In this state, there is a shift in the redox potential of these cells to a 
more oxidised environment (as measured by the glutathione/oxidised glutathione 
ratio) [28], and the nitroxide probe 7 is retained in its oxidised, less fluorescent form. 
 
As well as identifying these basal differences in the cellular redox environments of 
cells with varying metabolic activity, the probe is also able to detect redox changes in 
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the ‘normal’ reducing environment of proliferating cells which are placed under an 
artificial oxidative stress by metabolic inhibitors such as 2-deoxy-D-glucose (2DG) 
and rotenone (ROT). 
 
Since redox homeostasis is intimately linked with glucose metabolism [29, 30], 2DG 
was selected as an appropriate agent to block cellular glycolysis and thus shift the cell 
to a more oxidising environment. The products of normal glucose metabolism include 
pyruvate (due to glycolysis) and NADPH (due to the pentose phosphate pathway), 
both of which are important in regulating the cellular redox environment. Pyruvate, as 
well as being essential for energy production in the cell as the precursor for acetyl-
CoA, can scavenge pro-oxidants such as hydrogen peroxide and other hydroperoxides 
[31]. NADPH is also vitally important to redox homeostasis as it is the primary source 
of reducing equivalents for the glutathione/glutathione peroxidase/glutathione 
reductase system, as well as the thioredoxin/thioredoxin peroxidase/thioredoxin 
reductase system [32-34]. 
 
Rotenone, on the other hand, blocks the activity of NADH dehydrogenase in the 
mitochondrial electron transport chain and this results in an increase in the production 
of reactive oxygen species (ROS) [35-37].  
 
Treatment of confluent cultures of h TERT immortalised fibroblasts with either 2DG 
or rotenone alone, at varying concentrations, showed little change in the cellular 
redox capacity, that could be indicated by the fluorescein-nitroxide probe 7. In the 
case of 2DG treatment, restriction of the supply of NADPH does not significantly 
alter the cell’s ability to reduce the nitroxide probe to the hydroxylamine. Without an 
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additional oxidative insult, the alternate reducing equivalents remaining available to 
the cell are still able to facilitate nitroxide reduction. Similarly, treatment with 
rotenone at a number of concentrations does not appear to compromise the cellular 
redox environment. In this case, normal glucose metabolism in the absence of 2DG 
must still be able to provide and regenerate sufficient reducing equivalents to detoxify 
increased ROS production and to reduce the nitroxide probe to the hydroxylamine.  
 
When 2DG and ROT are applied in combination however, there is a significant 
impact on the cellular redox environment as indicated by a decrease in the number of 
cells able to reduce the nitroxide to the hydroxylamine (Figure 5, Panel D). A loss of 
available reducing equivalents in the form of NADPH, combined with an increase in 
ROS production results in the nitroxide probe remaining in the more oxidised, free-
radical and therefore less fluorescent form in the majority of cells. This reflects the 
more oxidised cellular redox environment now present in these cells that has been 
created by the combined 2DG/ROT treatment. These findings are consistent with a 
previous study on transformed fibroblasts which showed an increase in cytotoxicity 
when 2DG and rotenone were used in combination [37], and showcases the capability 
of the profluorescent nitroxide to probe the oxidative status within the cell. 
 
Flow cytometry shows that the response of the probe to cellular oxidative status 
occurs in a concentration-dependent manner with respect to 2DG (for a fixed rotenone 
concentration of 100 nM, Figure 6) and rotenone (for a fixed 2DG concentration of 20 
mM, Figure 7). 
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Figure 6. The proportion of cells retaining the oxidised form of the fluorescein-
nitroxide probe 7 (at fixed ROT concentration, of 100 nM) is dependent on the 
concentration of 2DG. Each data point is the mean of three measurements (± SD). 
Statistical relationship between means determined by two-sample, two-sided t tests. 
*p < 0.03 and **p < 0.01 vs cells containing no 2DG 
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Figure 7. The proportion of cells retaining the oxidised form of the fluorescein-
nitroxide probe 7 (at fixed 2DG concentration, of 20 mM) is dependent on the 
concentration of ROT. Each data point is the mean of three measurements (± SD). 
Statistical relationship between means determined by two-sample, two-sided t tests. 
*p < 0.03 vs cells containing no ROT 
 
Fluorescence Imaging 
As well as being well suited to flow cytometry experiments, the emission profile of 
the fluorescein-nitroxide (7) also allows for fluorescent imaging of biological 
samples. Visualisation of the subcellular regions to which the probe is localising 
potentially provides insight into the types of oxidative change occurring within cells 
as indicated by the flow cytometry results. Time-resolved imaging also allows 
analysis of the mode of uptake of the probe, as well as potentially demonstrating real-
time response to further oxidative insult or antioxidant treatment. 
 
 28
In order to assess the mechanism of uptake and metabolism of the probe in normal 
cells under basal physiological conditions, h TERT immortalised human fibroblasts 
were incubated with 1 µM of the fluorescein-nitroxide adduct, and visualised after 15 
minutes, 45 minutes, and 2 hours (Figure 8).  
 
 
Figure 8. Z-projection of deconvolved image stack of h TERT immortalised human 
fibroblasts incubated with fluorescein-nitroxide for 15 minutes, 45 minutes, and 2 
hours. Cells were washed with L-15 media prior to visualisation. 
 
Following 15 minutes incubation with 1 µM of the fluorescein-nitroxide adduct, 
fluorescence was observed in the intracellular compartments of the fibroblasts in what 
appear to be endocytotic vesicles. After 45 minutes incubation time, much of the 
fluorescent nitroxide probe had migrated from these vesicles to the plasma membrane. 
This membrane localisation remained apparent after two hours. Although in both the 
45 min and the 2 hour incubation time points some of the probe may still be seen in 
the endosomes, the majority of the material has migrated to the cellular membrane. 
 
In order to ascertain whether these endocytotic vesicles could be identified as, or fuse 
with, lysosomes at any stage of the incubation period, co-localisation experiments 
between the nitroxide probe and the commercially available, lysosome-specific probe 
LysoTracker
®
 Red were undertaken. Both probes were added to the cells 
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simultaneously and were subsequently visualised after incubation times of 15 mins, 
45 mins, and 2 hours as described previously (Figure 9). 
 
Figure 9. Z-projection of deconvolved image stack of h TERT immortalised human 
fibroblasts incubated with fluorescein-nitroxide and LysoTracker
®
 Red for 15 
minutes, 45 minutes, and 2 hours. Cells were washed with L-15 media prior to 
visualisation. Left panels show green fluorescence at 528 nm, middle panels show red 
fluorescence at 617 nm, and the right panels show the merged green and red 
fluorescence images. Movement of the endocytotic vesicles could be observed in both 
the red and green channels during live acquisition of image stacks. 
 
As observed previously, the fluorescein-nitroxide probe is initially contained within 
endocytotic vesicles (15 minutes) before the majority of the probe migrates to the 
cellular membrane (45 minutes and 2 hours). Co-staining of the lysosomes with 
LysoTracker
®
 Red in these samples indicates that the vesicles containing the nitroxide 
probe are co-localising with the lysosomes shown in red. Slight movement of the 
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lysosomes between the acquisition of each fluorescence channel prevented the direct 
overlap of the red and green fluorescence as the location of the vesicles were slightly 
different in each scan.  
 
Discussion 
Pro-oxidants are recognised as having a crucial role in various biological processes 
including the regulation of normal physiological processes [38], as well as 
contributing to the pathology of conditions such as Alzheimer’s disease [39]. In the 
case of diseases which have been linked to oxidative stress, antioxidant intervention is 
of potential therapeutic benefit. Therefore, detection of changes to the cellular redox 
environment as a result of pro-oxidant or antioxidant processes is important for 
understanding the mechanistic links between free radical chemistry and biological 
outcomes.  
 
The most effective way to define the mechanistic links between oxidative stress and 
various cellular processes is with real-time measurement of redox changes occurring 
in live cells. Fluorescent chemical probes are excellent tools in this regard, since they 
are able to provide spatial and temporal information with high sensitivity. There are 
varied examples of such probes in the literature, all of which rely on a ‘one-way’ 
detection method. This approach involves non-reversible reaction of a non-fluorescent 
probe molecule with a radical of interest to produce a detectable fluorescent product. 
Although challenges relating to probe specificity [40, 41] are being addressed [42, 
43], the non-reversible detection approach of this research remains unchanged. The 
advantage of using a nitroxide as the redox-sensitive element in the fluorescent probe 
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presented in this work is its ability to reversibly interconvert between the nitroxide 
and hydroxylamine. Since the ratio of these two states is a measure of the cellular 
redox environment [8, 11-15], the fluorescein nitroxide probe 7 allows dynamic 
detection of changes to the oxidative status of biological systems.  
 
Therefore, as well as providing specific detection of superoxide in cell-free systems, 
the nitroxide probe described here may also serve as a dynamic fluorescent indicator 
of the overall redox environment in cellular systems, which can be analysed using a 
variety of analytical techniques such as flow cytometry. Knowledge of the mechanism 
of uptake and localisation of the probe, as visualised using deconvolution 
fluorescence microscopy, also provides a powerful tool with which to identify the 
sites of redox changes occurring inside the cell. 
 
In summary, this new probe and imaging technology provides a reversible and real-
time response towards oxidative changes and may allow the testing of antioxidant 
therapies of potential benefit to a range of diseases linked to oxidative stress. 
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A. HPLC: 7 separated with 60 % MeOH/40 % H2O 
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B. The dependence of fluorescence emission intensity of 7 (―) and 8 (―) on pH 
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C. HPLC trace of fluorescein-nitroxide probe using fluorescence detector (Excitation: 
492 nm, Emission: 514 nm; Solvent A: MeCN + 0.1 % v/v TEAA, Solvent B: H2O + 
0.1 % v/v TEAA; gradient elution over 20 mins of 5:95 Solvent A:Solvent B to 100 % 
Solvent A) 
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D. HPLC trace of fluorescein-hydroxylamine using fluorescence detector (Excitation: 
492 nm, Emission: 514 nm; Solvent A: MeCN + 0.1 % v/v TEAA, Solvent B: H2O + 
0.1 % v/v TEAA; gradient elution over 20 mins of 5:95 Solvent A:Solvent B to 100 % 
Solvent A) 
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E. NMR spectrum of the fluorescein-hydroxylamine synthesised by hydrogenation 
with palladium on carbon catalyst (10 %) in MeOH. Once the reaction was complete, 
the reaction mixture was bubbled with nitrogen for approximately 30 mins to remove 
most of the MeOH. The crude product was then taken up in deuterated DMSO, 
filtered through a syringe filter and analysed by 
1
H NMR spectroscopy. 
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δH: (d6-DMSO); 1.23 (6H, br s), 1.41 (6H, br s), 6.55 (4H, m), 6.68 (2H, s), 7.10 (1H, 
s), 7.73 (1H, s), 7.82 (1H, s), 10.10 (1H, br). Residual solvent peaks from the filtered 
crude reaction mixture at 4.12 (OH from MeOH), 3.44 (H2O), 3.17 (CH3 from 
MeOH) and 2.50 (residual DMSO solvent peak). 
 
 
